A place for empowering people

The Florey’s staff and students are the bedrock of our research and success and have a strong commitment to excellence and integrity. We want everyone at the Florey to feel inspired by and connected to our collective vision and mission.

We have wonderful people who demonstrate enormous collective strength, and as a cohesive and connected organisation we are greater than the sum of our individual parts. We strive for a profound and positive impact on the local and global community. However, inspiration and ‘fire in the belly’ starts with individuals and it is the way we work that will empower our people to have great dreams and do outstanding things.

Our future focus starts with an unwavering commitment to diversity and inclusion and a desire to provide a place of tremendous opportunity for everyone.

What we’re doing

Researchers from the Florey attended a reception at Government House which recognised organisations and people involved in the field of overcoming drug and alcohol addiction. Pictured with Mr Anthony Howard AM QC, the Florey’s researchers are investigating how drugs and alcohol can change the brain’s structure, chemistry and function in the hope to fundamentally shift how addiction is understood and treated.

Attracting, developing and retaining the best and brightest people.

Embedding shared values and behaviours that support and empower our people.

Enhancing equality and diversity to ensure that the Florey is a great place to study and build a career.

Enabling the cross pollination of ideas and experiences that underpin wonderful research outcomes.

Victorian Treasurer and Minister for Economic Development, Mr Tim Pallas, Florey Director, Professor Steven Petrou, CEO of Praxis Precision Medicine, Dr Kiran Reddy and patient advocate, Ms Sara James, celebrated the establishment of the Praxis Precision Medicine’s Asia Pacific headquarters and research and development centre in Parkville. Founded by Dr Kiran Reddy, Praxis is a biotech company born out of more than a decade of research with the Florey, focused on delivering new medicines for patients with disorders including epilepsy, autism and mental illness.